C4 Therapeutics, Inc. Profile Avatar - Palmy Investing

C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7…

Biotechnology
US, Watertown [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

C4 Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

C4 Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of C4 Therapeutics, Inc..

End of CCCC's Analysis
CIK: 1662579 CUSIP: 12529R107 ISIN: US12529R1077 LEI: - UEI: -
Secondary Listings
CCCC has no secondary listings inside our databases.